Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

cellohealthinsight

- PMLiVE

Biosimilars eat into J&J’s Remicade sales

But its IL-23 inhibitor 'signals better times ahead'

- PMLiVE

Gilead gets OK for three-in-one hep C therapy in US

FDA clears the new product for the most common HCV genotypes

- PMLiVE

Creative effectiveness: international work that works

Creative Director Damien Parsonage explains how the creative department at Blue Latitude Health creates work that resonates with customers and delivers results.

Blue Latitude Health

- PMLiVE

Merck’s new health charity strikes partnership deal with Tanzania

The Merck Foundation will support oncology fellowship programmes for Tanzanian doctors

- PMLiVE

Is it time we stopped talking about adherence?

Delivering a fresh approach to patient care

Sanofi: Wearables are a core part of our digital trials strategy

Pharma firm partners with Parexel on patient sensor work

PharmaLex appoints Zabin Younes as associate director

She joins from ERA Consulting

- PMLiVE

Alcon’s return to growth gives Novartis ‘options’, says CEO

Sales up 3% to $1.5bn in second quarter for ailing eyecare division

- PMLiVE

Alcon’s return to growth gives Novartis ‘options’, says CEO

Sales up 3% to $1.5bn in second quarter for ailing eyecare division

- PMLiVE

Spark closes on first US gene therapy approval

FDA starts review of Luxturna for patients with inherited retinal disease

Pharma Brand Strategy 2.0

Learn about the building blocks of a great brand strategy that will have the potential to capture the full commercial value from a product.

An agency called Owen

- PMLiVE

Havas Group acquires SO What Global

Founders Scott Clark and Oliver Parsons will continue to lead the SO team

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links